Länder Analysen: Schweiz
| 06.01.23 | Novartis Underperform | Credit Suisse Group | |
| 06.01.23 | Novartis Underweight | Morgan Stanley | |
| 04.01.23 | DocMorris Sell | Deutsche Bank AG | |
| 03.01.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.12.22 | Novartis Underweight | Barclays Capital | |
| 20.12.22 | DocMorris Sell | UBS AG | |
| 19.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 19.12.22 | Givaudan Sell | UBS AG | |
|
Werbung
|
|||
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 13.12.22 | Givaudan Sell | UBS AG | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 09.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 02.12.22 | Swiss Re Sell | UBS AG | |
| 01.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 28.11.22 | Givaudan Sell | UBS AG | |
| 28.11.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 23.11.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 22.11.22 | Novartis Sell | Deutsche Bank AG | |
| 21.11.22 | Givaudan Sell | UBS AG | |
| 21.11.22 | UBS Underweight | Barclays Capital | |
| 16.11.22 | Givaudan Underperform | Bernstein Research | |
| 15.11.22 | DocMorris Sell | Deutsche Bank AG | |
| 04.11.22 | Swiss Re Underweight | Morgan Stanley | |
| 02.11.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 31.10.22 | Swiss Re Sell | UBS AG | |
| 31.10.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 27.10.22 | UBS Sell | Goldman Sachs Group Inc. | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | UBS Underweight | Barclays Capital | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 25.10.22 | DocMorris Underperform | Credit Suisse Group | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | Givaudan Underperform | Bernstein Research | |
| 21.10.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 20.10.22 | DocMorris Sell | UBS AG | |
| 20.10.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 19.10.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 19.10.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 19.10.22 | UBS Sell | Goldman Sachs Group Inc. | |
| 14.10.22 | Novartis Underweight | Barclays Capital | |
| 14.10.22 | Holcim Sell | Goldman Sachs Group Inc. | |
| 12.10.22 | Givaudan Underperform | Credit Suisse Group | |